Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -9.02 Million AUD | -45.8% |
| 2023 | -6.18 Million AUD | -69.87% |
| 2022 | -3.64 Million AUD | 5.96% |
| 2021 | -3.87 Million AUD | -71.64% |
| 2020 | -2.25 Million AUD | -16.28% |
| 2019 | -1.94 Million AUD | 60.92% |
| 2018 | -4.96 Million AUD | 44.61% |
| 2017 | -8.96 Million AUD | -22.66% |
| 2016 | -7.31 Million AUD | -34.67% |
| 2015 | -5.42 Million AUD | -35.66% |
| 2014 | -4 Million AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.6 Million AUD | -521.72% |
| 2024 FY | -9.02 Million AUD | -45.8% |
| 2024 Q1 | -580.58 Thousand AUD | 79.24% |
| 2024 Q4 | -5.41 Million AUD | 0.0% |
| 2023 FY | -6.18 Million AUD | -69.87% |
| 2023 Q2 | -4.67 Million AUD | -221.63% |
| 2023 Q3 | -1.68 Million AUD | 63.92% |
| 2023 Q4 | -2.79 Million AUD | -65.65% |
| 2023 Q1 | -1.45 Million AUD | 58.92% |
| 2022 Q4 | -3.54 Million AUD | 0.0% |
| 2022 FY | -3.64 Million AUD | 5.96% |
| 2022 Q2 | -2.08 Million AUD | 0.0% |
| 2021 Q4 | -2.44 Million AUD | 0.0% |
| 2021 Q2 | -1.42 Million AUD | 0.0% |
| 2021 FY | -3.87 Million AUD | -71.64% |
| 2020 Q4 | -1.37 Million AUD | 0.0% |
| 2020 FY | -2.25 Million AUD | -16.28% |
| 2020 Q2 | -888.94 Thousand AUD | 0.0% |
| 2019 FY | -1.94 Million AUD | 60.92% |
| 2018 FY | -4.96 Million AUD | 44.61% |
| 2017 FY | -8.96 Million AUD | -22.66% |
| 2016 FY | -7.31 Million AUD | -34.67% |
| 2015 FY | -5.42 Million AUD | -35.66% |
| 2014 FY | -4 Million AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 87.431% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 283.584% |
| SQZ Biotechnologies Company | -75.82 Million USD | 88.1% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 49.443% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 111.023% |
| Mesoblast Limited | -84.14 Million USD | 89.277% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -487.404% |
| Genus plc | 6.4 Million USD | 240.982% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 192.613% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -868.758% |
| Marizyme, Inc. | -34.08 Million USD | 73.53% |
| ContraFect Corporation | -56.88 Million USD | 84.14% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -8.058% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -98.098% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -543.572% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -216.534% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -228.002% |
| MultiCell Technologies, Inc. | -722.81 USD | -1248197.616% |
| Accustem Sciences Inc. | -3.74 Million USD | -140.839% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 84.704% |
| EV Biologics, Inc. | -483.06 Thousand USD | -1767.839% |
| Q BioMed Inc. | -3.44 Million USD | -161.864% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 354.882% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -2216.097% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -243.397% |
| Biomind Labs Inc. | -1 Million USD | -793.7% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -84.911% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -35.722% |
| Skye Bioscience, Inc. | -13.67 Million USD | 34.004% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -354.212% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -30024.265% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -78.865% |
| IMV Inc. | -38.67 Million USD | 76.668% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 43.144% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -366.872% |
| GB Sciences, Inc. | -1.42 Million USD | -535.182% |
| Alpha Cognition Inc. | -9.7 Million USD | 7.035% |
| HST Global, Inc. | -140.9 Thousand USD | -6303.387% |
| CSL Limited | 3.7 Billion USD | 100.244% |
| Halberd Corporation | -75.05 Thousand USD | -11922.412% |
| Enzolytics Inc. | -2.14 Million USD | -319.9% |
| Resverlogix Corp. | -12.74 Million USD | 29.227% |
| Affymax, Inc. | -15.04 Million USD | 40.032% |
| SYBLEU INC | -149.18 Thousand USD | -5948.277% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -184.787% |
| argenx SE | -425.04 Million USD | 97.877% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 83.745% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -764.255% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -471.298% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -164.989% |
| AVAX Technologies, Inc. | 6.69 Million USD | 234.812% |
| Zenith Capital Corp. | -8.94 Million USD | -0.893% |
| Genscript Biotech Corporation | -415.79 Million USD | 97.83% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -51692.779% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -267.481% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -5160.827% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 83.587% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -210.998% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -816.904% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -383.961% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -618.377% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -350.071% |
| BioStem Technologies, Inc. | -7.77 Million USD | -15.99% |
| ONE Bio Corp. | 13.68 Million USD | 165.949% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -4871.662% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -575.649% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -702.095% |
| Agentix Corp. | -1.37 Million USD | -557.757% |
| LadRx Corporation | -3.82 Million USD | -135.975% |
| Cell Source, Inc. | -4.32 Million USD | -108.603% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -2071.667% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1213.461% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1213.461% |
| NovAccess Global Inc. | -2.46 Million USD | -265.776% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -209.06% |
| Itoco Inc. | -919.14 Thousand USD | -881.659% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -112.882% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -706.329% |
| Kadimastem Ltd | -3.04 Million USD | -196.779% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -3347.43% |
| CytoDyn Inc. | -18.05 Million USD | 50.034% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -35747.517% |
| Mobile Lads Corp. | -554.55 Thousand USD | -1527.053% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -3999.828% |
| Qrons Inc. | -643.67 Thousand USD | -1301.762% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -1497.743% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -304.633% |
| Rebus Holdings, Inc. | -664 Thousand USD | -1258.858% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -396.764% |
| International Stem Cell Corporation | -663 Thousand USD | -1260.908% |
| Bioxytran, Inc. | -3.82 Million USD | -136.19% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -17040.616% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -44259.98% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 75.12% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -457.653% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -1126.202% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -190.03% |
| Neutra Corp. | -229.48 Thousand USD | -3831.752% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 48.556% |
| PureTech Health plc | -146.19 Million USD | 93.828% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 58.016% |
| IXICO plc | -1.43 Million USD | -527.893% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 4.933% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 92.592% |
| CSL Limited | 3.81 Billion USD | 100.237% |
| Cellectis S.A. | -108.85 Million USD | 91.711% |